BZAD-01

Overview

BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit , with a K i of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Depression | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > iGluR

Product Information

• Catalog No.: HY-121100
• CAS No.: 305339-41-7
• Molecular Formula: C16H12F6N2O
• Molecular Weight: 362.27
• Purity: 99.82%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source